Kawasaki, Japan

Yoko Obayashi

This inventor holds 1 USPTO granted patent. Top assignee: Ajinomoto Co., Ltd.. Active years: 1998.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yoko Obayashi. Retrieved from https://idiyas.com/inventor/yoko-obayashi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 1998

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Yoko Obayashi in Antitumor Compounds

Introduction

Yoko Obayashi, an innovative inventor based in Kawasaki, Japan, has made significant strides in the field of pharmaceutical research. With a keen focus on antitumor compounds, he has captured the attention of the scientific community, reflecting his dedication to improving cancer treatment.

Latest Patents

Yoko Obayashi holds a patent titled "Group of Antitumor Compounds and Method for Producing the Same." This valuable patent illustrates his contribution to the development of new therapeutic options for those affected by cancer, showcasing his inventive abilities and scientific expertise.

Career Highlights

Obayashi is associated with Ajinomoto Co., Ltd., a leading food and biotechnology company. His work involves significant research and development activities, aimed at creating effective solutions in the pharmaceutical sector. His accomplishments demonstrate not only his inventiveness but also his commitment to advancing health care.

Collaborations

Throughout his career, Yoko Obayashi has collaborated with talented individuals, including coworkers Toshihiko Yoshimura and Yuka Ikenoue. These partnerships foster innovation and enable the combination of diverse ideas that drive successful research outcomes.

Conclusion

Yoko Obayashi’s contributions to antitumor compound research exemplify the vital role of inventors in the medical field. As he continues his work at Ajinomoto Co., Ltd., the potential for new breakthroughs in cancer treatment remains promising, with hope for improved patient outcomes on the horizon.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…